Iranian Expert Makes Medicine Distribution Platform for Underprivileged Areas
“The main problem of pharmaceutical companies is their dependence on manpower and visitors to distribute their products, which limits access to cities and remote areas and hinders their market development,” Ali Boroumandi told ANA.
“We have investigated the wholesale sale of drugs. Due to the large number of pharmacies, our bargaining advantage with the manufacturers is high and it allows us to get the medicine from the manufacturers at a better price and supply them to the pharmacies,” he added.
“For instance, a company did not have a representative or visiting force in Kerman, but with the digital coverage we have provided throughout the country, we were able to introduce the product to Kerman and develop its market,” Boroumandi said.
In a relevant development in January, Iranian researchers at the University of Tabriz had also succeeded in identifying and preparing a new drug delivery system with the help of nanotechnology based on polysaccharides or covalent organic frameworks for targeted delivery of drugs to cancer cells.
“Direct prescription of anticancer drugs can cause many side effects due to accumulation in non-target organs, tissues or cells. Also, anticancer drug molecules have limitations like low stability, low targeting efficiency, low permeability, and uncontrolled drug release,” said Hassan Namazi, a PhD student in organic polymer chemistry at Dalhousie University in Canada and a professor at the University of Tabriz.
Noting that in recent years, new drug carrier systems, specially carriers based on porous nanoparticles with high loading capacity and controlled drug release, have largely resolved problems and restrictions, he said, “Covalent organic frameworks are the most remarkable emerging porous organic materials due to their unique properties.”
“In this research project, covalent organic frameworks with immune bonds obtained as a result of the reaction of different aldehydes and amines were used on a substrate of nanoparticles or polysaccharides which can be used for targeted delivery of drugs to cancer cells,” Namazi said.
4155/v
